KLK3 and prostate carcinoma: In addition to the abovementioned observations, the results of a large independent survey conducted in six European countries (France, Germany, Italy, Spain, Sweden, and the UK) and the USA clearly show a lack of awareness about prostate cancer, the PSA test, and early treatment among the general population.